EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study-Reference-Cited by-同舟云学术

EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study

Published:2014-08-20 Issue:11 Volume:35 Page:11647-11653
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Bilgin Doğru Elif,Dizdar Yavuz,Akşit Ece,Ural Feyyaz,Şanlı Öner,Yasasever Vildan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2514-8.pdf

Reference29 articles.

1. Van Hoorde L, Van Aken E, Mareel M. Collagen type I: a substrate and a signal for invasion. Prog Mol Subcell Biol. 2000;25:105–34.

2. Aksun SA, Özmen D, Bayındır O. Metalloproteinazlar, inhibitörleri ve ilişkili fizyolojik ve patolojik durumlar. Turk Klin J Med Sci. 2001;21:332–42.

3. Reel B. Matriks metalloproteinaz enzimleri ve ateroskleroz. Turk Klin J Med Sci. 2006;26:527–37.

4. van Hinsbergh VWM, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol. 2006;26:716–28.

5. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287–97.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAM12-Generated Basigin Ectodomain Binds β1 Integrin and Enhances the Expression of Cancer-Related Extracellular Matrix Proteins;International Journal of Molecular Sciences;2024-05-28

2. Exploring the ADAM12 Expression in Clear Cell Renal Cell Carcinoma: A Radiogenomic Analysis on CT Imaging;Academic Radiology;2024-03

3. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery;Biomedicines;2023-12-28

4. Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer;Clinical and Translational Oncology;2022-10-02

5. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma;Bioengineered;2022-01-30